-- FACTBOX: Largest M&A deals in pharma sector
-- 
-- Fri Jan 23, 2009 5:42am EST
-- http://www.reuters.com/article/2009/01/23/wyeth-pfizer-factbox-sb-idUSTRE50M2EA20090123

 

 Jan 23 (Reuters) - Pfizer Inc, the world's largest drugmaker by revenue, is in talks to acquire rival Wyeth in a deal that could be valued at more than $60 billion, the Wall Street Journal reported on its website. 

 Following is a list of the top ten M&A deals in the pharma sector: ACQUIROR                                    TARGET                  VALUE                     COMPLETED ($ billion) Pfizer Inc                              Warner-Lambert Co         88.77                            19/06/2000 Glaxo Wellcome PLC    SmithKline Beecham PLC  78.77                            27/12/2000 Sanofi-Synthelabo SA                   Aventis SA              65.65                           20/08/2004 Pfizer Inc                                     Pharmacia Corp          60.7                            15/04/2003 Roche Holding AG                           Genentech Inc           43.65 * ZENECA Group PLC                        Astra AB                31.77                        06/04/1999 Rhone-Poulenc SA                          Hoechst AG              28.35                        15/12/1999 Sandoz AG                                   Ciba-Geigy AG           28.22                         17/12/1996 Novartis AG                                         Alcon Inc               27.73 ** Monsanto Co           Pharmacia & Upjohn Inc             26.77                            31/03/2000 *  Announced July 21, 2008. ** Announced April 7, 2008. Source: Thomson Reuters; (Compiled by Jijo Jacob; Editing by David Cowell) ((Bangalore Editorial Reference Unit; RM: jijo.jacob.reuters.com@reuters.net, +91 80 4135 5839, fax +91 80 4135 5001))